🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

82 results for “Karyopharm” Clear

  1. Selinexor

    Karyopharm Therapeutics

    Solid Tumor

    phase 1 small molecule completed

    1 trial

  2. Selinexor Pill

    Karyopharm Therapeutics

    Hepatocellular Carcinoma

    phase 1 small molecule terminated

    1 trial

  3. Venetoclax

    Karyopharm Therapeutics

    Acute Leukemia of Ambiguous Lineage in Relapse

    phase 1 small molecule active

    1 trial

  4. Venetoclax

    Karyopharm Therapeutics

    Diffuse Large B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  5. Verdinexor

    Karyopharm Therapeutics

    Healthy

    phase 1 small molecule terminated

    1 trial

  6. decitabine

    Karyopharm Therapeutics

    Acute Myeloid Leukemia

    phase 1 small molecule completed

    1 trial

  7. mitoxantrone hydrochloride

    Karyopharm Therapeutics

    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

    phase 1 small molecule completed

    1 trial

  8. selinexor

    Karyopharm Therapeutics

    Recurrent Melanoma

    phase 1 small molecule completed

    1 trial

  9. selinexor

    Karyopharm Therapeutics

    B-cell Lymphoma

    phase 1 small molecule completed

    1 trial

  10. standard dose capecitabine

    Karyopharm Therapeutics

    Rectal Neoplasms

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources